fig3
![Circulating culprit or therapeutic bullseye: lipoprotein(a) in cardiovascular risk assessment and novel therapeutic prospects](https://image.oaes.cc/4d822b66-79e7-4bf1-92a6-e390952183a6/jca4035.fig.3.jpg)
Figure 3. Effect of lipid-lowering therapies on Lp(a) levels. CEPT: Cholesteryl ester transfer protein; Lp(a): lipoprotein(a); LLT: lipid-lowering therapy; PCSK9: proprotein convertase subtilisin/kexin type 9.
Figure 3. Effect of lipid-lowering therapies on Lp(a) levels. CEPT: Cholesteryl ester transfer protein; Lp(a): lipoprotein(a); LLT: lipid-lowering therapy; PCSK9: proprotein convertase subtilisin/kexin type 9.
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/